Nephros (NEPH) Non-Current Deffered Revenue (2011 - 2017)
Nephros (NEPH) posted Non-Current Deffered Revenue of $208000.0 for Q4 2017, down 7.56% on a QoQ basis from $225000.0 in Q3 2017, and down 25.18% year-over-year from $278000.0 in Q4 2016.
Powered by 
Analysis
Nephros (NEPH) Non-Current Deffered Revenue (2011 - 2017) Analysis & Trends
Nephros has reported Non-Current Deffered Revenue for 7 years, with the latest figure at $208000.0 in Q4 2017.
- On a quarterly basis, Non-Current Deffered Revenue fell 25.18% year-over-year to $208000.0 in Q4 2017; TTM through Dec 2017 was $208000.0, a 25.18% decrease from a year earlier, with the FY2017 full-year figure at $208000.0, down 25.18% from the prior year.
- Non-Current Deffered Revenue was $208000.0 for Q4 2017 at Nephros, down from $225000.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $531000.0 in Q1 2013, with the low at $176000.0 in Q3 2013.
- Average Non-Current Deffered Revenue over 5 years is $333833.3, with a median of $338500.0 recorded in 2015.
- The sharpest annual moves came in 2013 and 2014: Non-Current Deffered Revenue tumbled 80.02% in 2013, then soared 146.59% in 2014.
- Over 5 years, Non-Current Deffered Revenue stood at $176000.0 in 2013, then jumped by 136.93% to $417000.0 in 2014, then declined by 16.79% to $347000.0 in 2015, then fell by 19.88% to $278000.0 in 2016, then fell by 25.18% to $208000.0 in 2017.
- The last three Non-Current Deffered Revenue figures came in at $208000.0 (Q4 2017), $225000.0 (Q3 2017), and $243000.0 (Q2 2017), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | - |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 208,000.00 |
| Sep 30, 2017 | 225,000.00 |
| Jun 30, 2017 | 243,000.00 |
| Mar 31, 2017 | 261,000.00 |
| Dec 31, 2016 | 278,000.00 |
| Sep 30, 2016 | 295,000.00 |
| Jun 30, 2016 | 313,000.00 |
| Mar 31, 2016 | 330,000.00 |
| Dec 31, 2015 | 347,000.00 |
| Sep 30, 2015 | 365,000.00 |
| Jun 30, 2015 | 382,000.00 |
| Mar 31, 2015 | 400,000.00 |
| Dec 31, 2014 | 417,000.00 |
| Sep 30, 2014 | 434,000.00 |
| Jun 30, 2014 | 452,000.00 |
| Sep 30, 2013 | 176,000.00 |
| Jun 30, 2013 | 352,000.00 |
| Mar 31, 2013 | 531,000.00 |
| Dec 31, 2012 | 707,000.00 |
| Sep 30, 2012 | 881,000.00 |